Global Fecal Occult Testing market 2016-2020

Publisher Name :
Date: 01-Sep-2016
No. of pages: 89
Inquire Before Buying

Fecal occult testing is simple and non-invasive in nature, thereby increasing its preference among many physicians. The results of few of the fecal occult tests can be obtained rapidly through point-of-care (POC) test kits such as Alere's Clearview iFOB, and Beckman Coulter's Hemoccult II SENSA. For instance, the Clearview iFOB test is based on human hemoglobin and gastrointestinal bleeding, and can provide results in five minutes. Beckman Coulter's Hemoccult II SENSA slides allow people to collect fecal samples at home settings and send them to hospitals, laboratories, and diagnostic centers.

The analysts forecast global fecal occult testing market to grow at a CAGR of 4.82% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global fecal occult testing market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of fecal occult testing products used to perform colorectal cancer screening.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


The report, Global Fecal Occult Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • Beckman Coulter

  • Eiken Chemical

  • Epigenomics

  • Quidel


Other prominent vendors


  • Abbott Laboratories

  • AccuBioTech

  • Applied Proteomics

  • ASAN PHARM.

  • Assure Tech.

  • BIOHIT Healthcare

  • EDP Biotech

  • FUJIREBIO

  • GeneNews

  • NanoRepro

  • Nantong Egens Biotechnology

  • Orion Diagnostica

  • Polymedco

  • Quest Diagnostics

  • Randox

  • VolitionRx


Market driver


  • Government initiatives and pilot programs worldwide

  • For a full, detailed list, view our report


Market challenge


  • High cost of FITs and limited reimbursement

  • For a full, detailed list, view our report


Market trend


  • Direct-to-consumer laboratory testing

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2020 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

  • What are the market opportunities and threats faced by the key vendors?

  • What are the strengths and weaknesses of the key vendors?

Global Fecal Occult Testing market 2016-2020

Table of Contents

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market Overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 06: Market segmentation by product
Global fecal occult testing market by FIT
Global fecal occult testing market by guaiac test
Global fecal occult testing market by stool DNA test

PART 07: Market segmentation by end-user
Global fecal occult testing market by hospitals
Global fecal occult testing market by clinical diagnostic laboratories
Global fecal occult testing market by physicians' office laboratories

PART 08: Geographical segmentation
Fecal occult testing market in Americas
Fecal occult testing market in EMEA
Fecal occult testing market in APAC

PART 09: Market drivers
Rise in geriatric population
Government initiatives and pilot programs worldwide
Shift toward patient-centered model (POC FITs) for home use

PART 10: Impact of drivers

PART 11: Market challenges
High cost of FITs and limited reimbursement
Inaccuracies in diagnosis
Limited awareness and reluctance of physicians to recommend fecal occult testing

PART 12: Impact of drivers and challenges

PART 13: Market trends
Collaboration between research centers and manufacturers
Online marketing of fecal occult immunological test devices
Direct-to-consumer laboratory testing

PART 14: Vendor landscape
Competitive scenario

PART 15: Key vendor analysis
Geographical presence: Major vendors
Beckman Coulter
Eiken Chemical
Epigenomics
Quidel
Key news
Other prominent vendors

PART 16: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Global fecal occult testing market: Three significant estimations
Exhibit 02: Product offerings
Exhibit 03: Colorectal cancer screening tests: Advantages and disadvantages of fecal occult testing
Exhibit 04: Scale of colorectal cancer cases in UK
Exhibit 05: Adoption of Cologuard in US 2014-2015
Exhibit 06: Segmentation of global fecal occult testing market
Exhibit 07: Global fecal occult testing market: Impact assessment
Exhibit 08: Global fecal occult testing market 2015-2020 ($ millions)
Exhibit 09: New cases and deaths related to colorectal cancer per 100,000 people in US 2004-2014
Exhibit 10: Government guidelines and support in some developed countries
Exhibit 11: Five forces analysis
Exhibit 12: Global fecal occult testing market by product 2015 and 2020
Exhibit 13: Global fecal occult testing market by FIT: An overview
Exhibit 14: Global fecal occult testing market by FIT 2015-2020 ($ millions)
Exhibit 15: Comparison of FIT and guaiac test
Exhibit 16: Global fecal occult testing market by guaiac test: An overview
Exhibit 17: Global fecal occult testing market by guaiac test 2015-2020 ($ millions)
Exhibit 18: Global fecal occult testing market by stool DNA test: An overview
Exhibit 19: Global fecal occult testing market by stool DNA test 2015-2020 ($ millions)
Exhibit 20: Global fecal occult testing market segmentation by end-user 2015
Exhibit 21: Revenue generated by diagnostic and medical laboratories in US 2009-2014
Exhibit 22: Global fecal occult testing market segmentation by geography 2015 and 2020
Exhibit 23: Fecal occult testing market in Americas: An overview
Exhibit 24: Fecal occult testing market in Americas 2015-2020 ($ millions)
Exhibit 25: Fecal occult testing market in Americas: Metrics analysis for various countries 2015 and 2020
Exhibit 26: Fecal occult testing market in US: Key takeaways
Exhibit 27: Fecal occult testing market in EMEA: An overview
Exhibit 28: Colorectal cancer mortality per 100,000 individuals in European countries 2003 and 2013
Exhibit 29: Fecal occult testing market in EMEA 2015-2020 ($ millions)
Exhibit 30: Fecal occult testing market in EMEA: Metrics analysis of various countries 2015 and 2020
Exhibit 31: Fecal occult testing market in UK: Key takeaways
Exhibit 32: Fecal occult testing market in APAC: An overview
Exhibit 33: Colorectal cancer mortality per 100,000 individuals in APAC 2003 and 2013
Exhibit 34: Fecal occult testing market in APAC 2015-2020 ($ millions)
Exhibit 35: Fecal occult testing market in APAC: Metrics analysis for various countries 2015 and 2020
Exhibit 36: People in age group 60 years and above worldwide 2010-2050
Exhibit 37: Government initiatives for colorectal cancer and fecal occult testing in some countries
Exhibit 38: Some POC FITs available in market
Exhibit 39: Impact of drivers
Exhibit 40: Study results: Potential barriers affecting adoption of FOBTs
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Some collaborations and their impact
Exhibit 43: Some companies and their distribution partners
Exhibit 44: Global fecal occult testing market: Competitive structure analysis 2015
Exhibit 45: Global fecal occult testing market: Competitive landscape analysis
Exhibit 46: Market penetration of vendors of fecal occult testing kits 2015
Exhibit 47: Global fecal occult testing market: Strategic success factors of companies
Exhibit 48: Major vendors: Regional analysis
Exhibit 49: Beckman Coulter: Profile summary
Exhibit 50: Beckman Coulter: Strength analysis
Exhibit 51: Beckman Coulter: Growth strategy matrix
Exhibit 52: Beckman Coulter: Opportunity assessment
Exhibit 53: Eiken Chemical: Profile summary
Exhibit 54: Eiken Chemical: Strength analysis
Exhibit 55: Eiken Chemical: Growth strategy matrix
Exhibit 56: Eiken Chemical: Opportunity assessment
Exhibit 57: Epigenomics: Profile summary
Exhibit 58: Epigenomics: Strength analysis
Exhibit 59: Epigenomics: Growth strategy matrix
Exhibit 60: Epigenomics: Opportunity assessment
Exhibit 61: Quidel: Profile summary
Exhibit 62: Quidel: Strength analysis
Exhibit 63: Quidel: Growth strategy matrix
Exhibit 64: Quidel: Opportunity assessment
Exhibit 65: Other prominent vendors

  • Adenovirus 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 205
    The report presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Adenovirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices ......
  • Aeromonads 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 200
    The report presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices ......
  • Campylobacter 2017-2021: Hospitals, Commercial Labs, Physician Offices, Public Health Labs--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 230
    The report presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Campylobacter definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices......
  • Chancroid 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 220
    The report presents a detailed analysis of the Chancroid diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chancroid definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices  &......
  • Chlamydia 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 184
    The report presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices  &......
  • Clostridium 2017-2021: Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 225
    The report presents a detailed analysis of the Clostridium diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Clostridium definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices&nbs......
  • Cytomegalovirus (CMV) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 231
    The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Blood Banks    ......
  • Coxsackievirus 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 190
    The report presents a detailed analysis of the Coxsackievirus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Coxsackievirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices......
  • Cryptosporidium 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 207
    The report presents a detailed analysis of the Cryptosporidium diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cryptosporidium definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Office......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs